We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Byotrol Plc | LSE:BYOT | London | Ordinary Share | GB00B0999995 | ORDS 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.125 | 0.05 | 0.20 | 0.125 | 0.125 | 0.13 | 447,501 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.59M | -1.69M | -0.0037 | -0.32 | 544.67k |
Date | Subject | Author | Discuss |
---|---|---|---|
05/9/2016 09:17 | If Byotrol is left as the one that can prove efficacy, it could be very positive. If not its a big downer | brownson | |
02/9/2016 21:39 | FDA: " Antibacterial soap? You can skip it --- Use plain soap and water." 2/9/2016 | greedfear | |
25/8/2016 15:20 | Is that the end of the little flurry of activity? I presume we are stuck at this level for the next year or two while profitability gets ever closer , though never quite happens | brownson | |
23/8/2016 17:31 | the way i see it if any one large co adopts this then every big cleanser company will have to license it as the big marketing spend of anyone of them will make hay with the Byotrol advantages. The ARM model comes to mind. Tiny fees x massive volume markets. | tonsil | |
23/8/2016 17:28 | I told you Mud had called the bottom - classic!! This was always going to be a licensed tech - the cleaning materials industry is just far too monopolistic to allow a minnow manufacturer in | tonsil | |
23/8/2016 13:58 | It was waiting for you to bog off mud. | maxk | |
22/8/2016 20:24 | cant see where anyone has posted the last RNS so here is Byotrol plc, the specialist anti-microbial technology company, is pleased to announce its final results for the 12 months ended 31 March 2016. We last updated the market in early July; we are pleased to confirm that our final, audited results are in line with that update. Highlights of the year include: EBITDA loss before exceptionals of £449k versus £526k in the previous year Sharply narrowed loss after tax of £532k (after all exceptionals and tax credits) versus a loss of £749k the previous year Cash and cash equivalents of over £1mn, compared to £287k in the prior year Continued moves to higher margin transactions, especially by way of licensing and development deals, including with KYORIN Pharmaceutical Co., Ltd (hand sanitisers in Japan), Rentokil Initial plc (hand sanitisers in UK washrooms) and Beaphar NA (surface care products for pet environments) in continental Europe Further and expanded agreement to develop and commercialise long-lasting biocidal products for hard surfaces with Solvay Novecare, a world leader in specialty polymers and surfactants and a global business unit of the international chemical group Solvay SA (“Solvay"). We also confirm continued progress in the technical tests required for formal Environmental Protection Agency (EPA) approval of our surface sanitising products in the US, with an expected registration filing date in early December 2016. Annual Report & Accounts for the year ended 31 March 2016 have today been posted to shareholders together with the Notice of Annual General Meeting, which will be held at 10am on 22 September 2016 at the offices of finnCap at 60 Broad Street, London EC2M 1JJ. An electronic copy of the Annual Report and Accounts is also available from the Company’s website: www.byotrol.co.uk. Outlook Trading for the current year to 31 March 2017 is proceeding to plan, with continued emphasis on higher margin contracts and customers. As previously notified to shareholders, under the terms of the agreement with Solvay, Solvay will be making substantial payments to the Company. All of those payments are fully committed and will be made in the second half of the current financial year. David Traynor, Chief Executive of Byotrol plc comments: “We are now showing progress in turning our low-margin, product sales business into a higher margin technology company. We are very confident about our future.” | tonsil | |
19/8/2016 19:23 | I've now tried my 3 nearest Boots and you can't get the Byotrol hand cleanser in any of them. BYT says they're getting revenue from the new product, but it isn't listed on their website and certainly isn't in stores. There's still a gap between ambition and execution. | supernumerary | |
19/8/2016 19:05 | Tosco are knocking out the Byotrol cleaner at £0.70 now or you can have the cheepo anti bac generic version @ £0.50: And Dettol (anti bac) was marked at a quid a go (in store) Sounds like a race to the bottom on the cleaner stakes. | maxk | |
19/8/2016 18:03 | Mudbath out!That is definitely calling the bottom on this. Buffet said investing transfers wealth from the impatient to the patient. . . | tonsil | |
19/8/2016 17:50 | The oldest and the most wizened maybe emeraldbra. | mudbath | |
19/8/2016 14:20 | Mud that is astonishing and not a little sad perhaps. Had you down as the oldest and the wisest. Get back in quick ! lol | emeraldzebra | |
18/8/2016 15:18 | Not everyone is as impressed though. From the pen of IdeasByScience:- "That’s an enviable list of customers / prospects that have not delivered – the comment attached to Rentokil perhaps explains perfectly why Byotrol is where it is: seeing day and saying it is night. To use a metaphor, the emperor’s new clothes fit but are very run of the mill style wise. Keep on passing the tests, but we are out at 4p, bitterly disappointed with an in at 13p." It may come right for BYOT but I too am now out. | mudbath | |
18/8/2016 10:05 | Hi Muddo (yes, long time no see), firth and all Byoteers. Results look ok to me (a meaningless statement)and technicals are starting to look promising (I've said that before and regretted it). But could this be the turning point? The Jim Crowley effect? I live in hope. | shrout | |
18/8/2016 09:28 | Keep spreading that message Maxk!!! Its music to my ears,up here in the Vale of York!!! | firth | |
18/8/2016 09:07 | COBBLERS ! | mudbath | |
18/8/2016 08:42 | It's grim oop north. | maxk | |
18/8/2016 08:17 | I haven't paid much attention to these since participating in the placing last year (the company seems to have a zero communications policy), but I see the AGM is in London this year, so I think I will go along to hear what they are all about and to fire a few questions from the chairman's statement: I do encourage you to come and see us at our AGM. Last year we had some very searching questions and received some excellent free advice from experienced shareholders. We welcome the two-way communication and hope for even more questions this year. After 2 years of holding the AGM in our offices, which is definitely our preference, we have decided to hold this year's meeting in London in order to encourage those southern shareholders who would like to come but would otherwise be discouraged by the journey north. Be careful what you wish for! | timbo003 | |
15/8/2016 14:54 | Sorry shrout(long time no see)but its only a bit of "off topic",to help alleviate the building lassitude brought about through my involvement with Byotrol. Jim Crowley may,or may not,be a route to my securing a tranche of new investment money. .Not at 7-1 though;although this might start to look a bit tasty by the end of Wednesday 17th August,imo. | mudbath | |
15/8/2016 14:30 | Thanks Tonsil will give it a go. Depends Shrout if he keeps riding winners. Got off to a great start today with a winner in the first. | firth | |
15/8/2016 13:57 | is Jim Crowley the public face of Byotrol? Have I missed something? | shrout | |
15/8/2016 13:21 | Try Bordeaux mixtureIt's an old remedy. | tonsil |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions